Results of shareholder votes disclosed under 8-K Item 5.07.
Transocean Ltd. shareholders approved Election of the members of the Compensation Committee, each for a term extending until completion of the next Annual General Meeting.
“7. Proposal regarding the election of the members of the Compensation Committee, each for a term extending until completion of the next Annual General Meeting.”
Transocean Ltd. shareholders approved Election of the Chair of the Board of Directors for a term extending until completion of the next Annual General Meeting.
“6. Proposal regarding the election of the Chair of the Board of Directors for a term extending until completion of the next Annual General Meeting.”
Transocean Ltd. shareholders approved Election of 11 directors, each for a term extending until completion of the next Annual General Meeting.
“5. Proposals regarding the election of 11 directors, each for a term extending until completion of the next Annual General Meeting.”
Transocean Ltd. shareholders approved Approval of Shares authorized for issuance.
“4. Proposal regarding the approval of Shares authorized for issuance.”
Transocean Ltd. shareholders approved Appropriation of the Accumulated Losses for Fiscal Year 2025.
“3. Proposal regarding the Appropriation of the Accumulated Losses for Fiscal Year 2025.”
Transocean Ltd. shareholders approved Discharge of the Members of the Board of Directors and the Executive Management Team from liability for activities during Fiscal Year 2025.
“2. Proposal regarding the discharge of the Members of the Board of Directors and the Executive Management Team from liability for activities during Fiscal Year 2025.”
Transocean Ltd. shareholders approved Advisory vote to approve the Company’s Swiss Statutory Report on Non-Financial Matters Report for Fiscal Year 2025.
“1. (C) Proposal regarding the advisory vote to approve the Company’s Swiss Statutory Report on Non-Financial Matters Report for Fiscal Year 2025.”
Transocean Ltd. shareholders approved Advisory vote to approve the Company’s Swiss Statutory Compensation Report for Fiscal Year 2025.
“1. (B) Proposal regarding the advisory vote to approve the Company’s Swiss Statutory Compensation Report for Fiscal Year 2025.”
Transocean Ltd. shareholders approved Approval of the 2025 Annual Report, including the Audited Consolidated Financial Statements and Audited Statutory Financial Statements for Fiscal Year 2025.
“1. (A) Proposal regarding the approval of the 2025 Annual Report, including the Audited Consolidated Financial Statements of the Company. for Fiscal Year 2025 and the Audited Statutory Financial Statements of the Company for Fiscal Year 2025.”
Ultra Clean Holdings, Inc. shareholders approved Approval of the amendment and restatement of the Company’s employee stock purchase plan to increase the number of shares available for issuance under the ESPP by an additional 450,000 shares at the 2026-05-22 meeting.
“Proposal 5 Approval of the amendment and restatement of the Company’s employee stock purchase plan (the “ESPP”) to increase the number of shares available for issuance under the ESPP by an additional 450,000 shares. For Against Abstain Broker Non-Votes 35,885,605 23,182 108,830 4,399,277”
Ultra Clean Holdings, Inc. shareholders approved Approval of the amendment and restatement of the Company’s stock incentive plan to increase the number of shares available for issuance under the Plan by an additional 3,500,000 shares at the 2026-05-22 meeting.
“Proposal 4 Approval of the amendment and restatement of the Company’s stock incentive plan (the “Plan”) to increase the number of shares available for issuance under the Plan by an additional 3,500,000 shares. For Against Abstain Broker Non-Votes 34,373,240 1,526,066 118,311 4,399,277”
Ultra Clean Holdings, Inc. shareholders approved Approval, by non-binding advisory vote, of the compensation paid by the Company to its Named Executive Officers at the 2026-05-22 meeting.
“Proposal 3 Approval, by non-binding advisory vote, of the compensation paid by the Company to its Named Executive Officers. For Against Abstain Broker Non-Votes 35,100,113 773,047 144,457 4,399,277”
Ultra Clean Holdings, Inc. shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP to serve as the Company’s independent registered public accounting firm for fiscal 2026 at the 2026-05-22 meeting.
“Proposal 2 Ratification of the appointment of PricewaterhouseCoopers LLP to serve as the Company’s independent registered public accounting firm for fiscal 2026. For Against Abstain 40,130,181 183,200 103,513”
Ultra Clean Holdings, Inc. shareholders approved Election of directors for a one-year term at the 2026-05-22 meeting.
“Proposal 1 Election of directors for a one-year term. Director For Against Abstain Broker Non-Votes Thomas T. Edman 35,583,689 420,800 13,128 4,399,277 James Xiao 35,497,518 506,734 13,365 4,399,277 Clarence L. Granger 35,515,152 489,995 12,470 4,399,277 David T. ibnAle 33,590,773 2,413,324 13,520 4,399,277 Emily M. Liggett 33,594,708 2,411,196 11,713 4,399,277 Ernest E. Maddock 35,812,702 193,074 11,841 4,399,277 Jacqueline A. Seto 35,604,277 401,727 11,613 4,399,277 Joanne Solomon 35,883,333 123,624 10,660 4,399,277”
APA Corp shareholders approved Approval of Amendment to the 2016 Omnibus Compensation Plan.
“Proposal 4 — Approval of Amendment to the 2016 Omnibus Compensation Plan . The Amendment as disclosed in the Proxy Statement was approved by the majority of shares voted, excluding abstentions and broker non-votes. For Against Abstentions Broker Non-Votes 266,499,823 10,989,332 642,903 34,089,789”
APA Corp shareholders approved Non-Binding Advisory Vote on Executive Compensation.
“Proposal 3 — Non-Binding Advisory Vote on Executive Compensation. In a non-binding advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the Proxy Statement (commonly known as “say on pay”), the compensation of the Company’s named executive officers was approved by the majority of shares voted, excluding abstentions and broker non-votes. For Against Abstentions Broker Non-Votes 238,710,645 38,762,516 658,897 34,089,789”
APA Corp shareholders approved Ratification of Appointment of Independent Auditor.
“Proposal 2 — Ratification of Appointment of Independent Auditor. The appointment of Ernst & Young LLP as the Company’s independent auditor for fiscal year 2026 was ratified by the majority of shares voted, excluding abstentions and broker non-votes. For Against Abstentions Broker Non-Votes 307,082,415 4,653,628 485,804 0”
APA Corp shareholders approved Election of Directors.
“Proposal 1 — Election of Directors. The following nominees for directors were elected to serve one-year terms expiring at the 2027 annual meeting of shareholders by the majority of shares voted, excluding abstentions and broker non-votes. Nominee For Against Abstentions Broker Non-Votes Annell R. Bay 269,919,835 7,802,862 409,361 34,089,789 John J. Christmann IV 275,118,068 2,608,513 405,477 34,089,789 Juliet S. Ellis 271,823,321 5,685,806 622,931 34,089,789 Kenneth M. Fisher 276,348,675 1,366,864 416,519 34,089,789 Charles W. Hooper 274,795,166 2,918,985 417,906 34,089,789 Chansoo Joung 274,003,759 3,708,825 419,474 34,089,789 H. Lamar McKay 276,435,125 1,286,135 410,798 34,089,789 Peter A. Ragauss 274,587,738 3,118,147 426,173 34,089,789 David L. Stover 275,026,460 2,699,058 406,540 34,089,789 Anya Weaving 275,421,441 2,081,920 628,696 34,089,789”
AEMETIS, INC shareholders approved Ratification of KPMG LLP as independent registered public accounting firm at the 2026-05-20 meeting.
“Proposal 2: Ratification of Auditor For Against Abstain Broker Non-Votes 37,777,860 85,378 376,596 0”
AEMETIS, INC shareholders approved Election of Director Nominee at the 2026-05-20 meeting.
“Proposal 1: Election of Director Nominee For Withhold Broker Non-Votes Lydia I. Beebe 18,110,640 627,847 19,501,347”
Vera Therapeutics, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-05-21 meeting.
“Proposal 3 – Advisory Vote on Executive Compensation. The Company’s stockholders approved, on an advisory basis, the compensation awarded to the Company’s named executive officers, as disclosed in the Proxy Statement. The final voting results are as follows: For Against Abstain Broker Non-Votes 56,585,568 2,433,537 84,276 2,863,469”
Vera Therapeutics, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-05-21 meeting.
“Proposal 2 – Ratification of the Appointment of Independent Registered Public Accounting Firm. The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. The final voting results are as follows: For Against Abstain 61,834,842 44,710 87,298”
Vera Therapeutics, Inc. shareholders approved Election of Directors at the 2026-05-21 meeting.
“Proposal 1– Election of Directors. The Company’s stockholders elected the three persons listed below as Class II Directors, each to serve until the Company’s 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or, if sooner, such director’s death, resignation or removal. The final voting results are as follows: Votes For Votes Withheld Broker Non-Votes Michael M. Morrisey, Ph.D. 45,288,710 13,814,671 2,863,469 Patrick G. Enright 54,697,296 4,406,085 2,863,469 James R. Meyers 58,946,269 157,112 2,863,469”
TaskUs, Inc. shareholders approved Ratification of Appointment of KPMG LLP as Independent Registered Public Accounting Firm at the 2026-05-21 meeting.
“For Against Abstain Broker Non-Votes 580,193,071 143,134 18,233 0”
TaskUs, Inc. shareholders approved Election of Class II Directors at the 2026-05-21 meeting.
“For Withheld Broker Non-Votes Jaspar Weir 574,749,347 942,204 4,662,887 Michelle Gonzalez 575,621,993 69,558 4,662,887 Amit Dalmia 574,737,643 953,908 4,662,887”
Viking Therapeutics, Inc. shareholders approved Approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement at the 2026-05-19 meeting.
“Proposal No. 3. To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement: Votes For Votes Against Abstentions Broker Non-Votes 30,045,938 12,763,135 401,396 36,879,063”
Viking Therapeutics, Inc. shareholders approved Ratify the selection of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-19 meeting.
“Proposal No. 2. To ratify the selection of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for its fiscal year ending December 31, 2026: Votes For Votes Against Abstentions 78,368,957 1,241,969 478,606”
Viking Therapeutics, Inc. shareholders approved Elect J. Matthew Singleton and S. Kathryn Rouan, Ph.D. as Class II directors at the 2026-05-19 meeting.
“Proposal No. 1. To elect the following nominees as Class II directors to serve until the Company’s 2029 annual meeting of stockholders or until such director’s respective successor is duly elected and qualified: Director Nominee Votes For Votes Withheld Broker Non-Votes J. Matthew Singleton 28,648,459 14,562,012 36,879,061 S. Kathryn Rouan, Ph.D. 21,960,203 21,250,268 36,879,061”
TUTOR PERINI CORP shareholders approved Approval of the Compensation of the Company’s Named Executive Officers on an Advisory (Non-binding) Basis.
“The Company’s shareholders cast their votes with respect to the approval of the compensation of the Company's named executive officers on an advisory (non-binding) basis. The final voting results on this proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 38,631,812 952,357 283,064 5,960,026”
TUTOR PERINI CORP shareholders approved Ratification of Appointment of Independent Auditor at the 2026-12-31 meeting.
“The Company's shareholders ratified the appointment of Deloitte & Touche LLP, an independent registered public accounting firm, as independent auditors of the Company for the year ending December 31, 2026. The final voting results on this proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 44,877,918 937,200 12,141 0”
TUTOR PERINI CORP shareholders approved Election of Directors.
“The Company's shareholders elected each of the following 10 nominees for director to serve until the Company's 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified. The final voting results for the election of directors were as follows: Elected Directors Votes For Votes Against Abstentions Broker Non-Votes Ronald N. Tutor 38,926,119 917,257 23,857 5,960,026 Gary G. Smalley 39,410,176 436,392 20,665 5,960,026 Peter Arkley 38,956,354 891,377 19,502 5,960,026 Jigisha Desai 36,091,008 3,755,431 20,794 5,960,026 Sidney J. Feltenstein 39,169,454 675,126 22,653 5,960,026 Robert C. Lieber 39,067,451 775,638 24,144 5,960,026 Dennis D. Oklak 39,483,643 359,446 24,144 5,960,026 Raymond R. Oneglia 38,220,426 1,622,382 24,425 5,960,026 Dale Anne Reiss 38,815,159 1,028,579 23,495 5,960,026 Shahrokh (“Rock”) Shah 39,522,340 318,864 26,029 5,960,026”
OMNICELL, INC. shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2026-05-19 meeting.
“Proposal No. 5: Ratification of the Selection of Independent Registered Public Accounting Firm”
OMNICELL, INC. shareholders approved Approval of an Amendment to the Company’s Amended and Restated Certificate of Incorporation at the 2026-05-19 meeting.
“Proposal No. 4: Approval of an Amendment to the Company’s Amended and Restated Certificate of Incorporation”
OMNICELL, INC. shareholders approved Approval of an Amendment to the Omnicell, Inc. 2009 Equity Incentive Plan, as Amended at the 2026-05-19 meeting.
“Proposal No. 3: Approval of an Amendment to the Omnicell, Inc. 2009 Equity Incentive Plan, as Amended”
OMNICELL, INC. shareholders approved Advisory Vote to Approve Named Executive Officer Compensation at the 2026-05-19 meeting.
“Proposal No. 2: Advisory Vote to Approve Named Executive Officer Compensation”
OMNICELL, INC. shareholders approved Election of Three Class I Directors at the 2026-05-19 meeting.
“Proposal No. 1: Election of Three Class I Directors to Hold Office Until the 2029 Annual Meeting of Stockholders”
Callaway Golf Co shareholders approved Advisory Vote on Executive Compensation at the 2026-05-21 meeting.
“Proposal 3: Advisory Vote on Executive Compensation The Company’s shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers. The following sets forth the results of the voting with respect to this proposal: Shares Voted For Against Abstentions Broker Non-Votes 136,918,067 8,942,872 585,222 13,927,308”
Callaway Golf Co shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-21 meeting.
“Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The Company’s shareholders ratified, on an advisory basis, the Audit Committee’s appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The following sets forth the results of the voting with respect to this proposal: Shares Voted For Against Abstentions 156,259,310 3,553,082 561,077”
Callaway Golf Co shareholders approved Annual Election of Directors at the 2026-05-21 meeting.
“Proposal 1: Annual Election of Directors The voting results for the annual election of directors are as follows: Shares Voted Name of Candidate For Against Abstain Broker Non-Votes Oliver G. (Chip) Brewer III 144,881,105 1,012,437 552,619 13,927,308 John F. Lundgren 141,187,733 4,702,183 556,245 13,927,308 Thomas G. Dundon 143,624,916 2,266,864 554,381 13,927,308 Russell L. Fleischer 143,052,952 2,837,157 556,052 13,927,308 Bavan M. Holloway 144,382,805 1,507,326 556,030 13,927,308 Mark D. Mandel 145,294,838 594,819 556,504 13,927,308 Adebayo O. Ogunlesi 136,193,872 9,691,484 560,805 13,927,308 Linda B. Segre 142,072,235 3,799,761 574,165 13,927,308 Anthony S. Thornley 142,124,785 3,763,640 557,736 13,927,308”
STONERIDGE INC shareholders approved Approve Amendment No. 1 to the Stoneridge, Inc. 2025 Long-Term Incentive Plan.
“4. The proposal to approve Amendment No. 1 to the Stoneridge, Inc. 2025 Long-Term Incentive Plan was approved by the following votes: For Against Abstain Broker Non-Votes 17,773,424 3,557,150 127,742 2,620,208”
STONERIDGE INC shareholders approved Advisory resolution to approve 2025 compensation of Named Executive Officers.
“3. A non-binding advisory resolution to approve the 2025 compensation paid to the Company’s Named Executive Officers was approved by the following votes: For Against Abstain Broker Non-Votes 15,986,309 5,458,156 13,851 2,620,208”
STONERIDGE INC shareholders approved Ratify appointment of Ernst & Young LLP as independent registered public accounting firm for 2026 at the 2026-12-31 meeting.
“2. The proposal to ratify the appointment of Ernst & Young LLP, as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was approved by the following votes: For Against Abstain Broker Non-Votes 23,883,582 194,854 88 —”
STONERIDGE INC shareholders approved Election of nine directors for one-year terms.
“At the 2026 Annual Meeting the following matters were voted on by the Company’s shareholders. The matters voted upon and the results, as certified by the Inspector of Elections, were as follows: 1. The nine Company nominees for election to the Board of Directors were elected, each for a one-year term, by the following votes: Nominee For Withheld Broker Non-Votes Aron R. English 21,416,977 41,339 2,620,208 Ira C. Kaplan 18,487,949 2,970,367 2,620,208 Kim Korth 17,981,620 3,476,696 2,620,208 William M. Lasky 19,394,736 2,063,580 2,620,208 Natalia Noblet 21,282,594 175,722 2,620,208 Carsten J. Reinhardt 20,842,937 615,379 2,620,208 Sheila Rutt 20,338,981 1,119,335 2,620,208 Frank S. Sklarsky 20,744,637 713,679 2,620,208 James Zizelman 21,267,549 190,767 2,620,208”
Ardent Health, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm at the 2026-05-20 meeting.
“The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, as follows: For Against Abstentions Broker Non-Votes 97,852,830 918,233 7,763 0”
Ardent Health, Inc. shareholders approved Advisory vote on executive compensation at the 2026-05-20 meeting.
“The stockholders approved on a non-binding advisory basis the compensation paid by the Company to its named executive officers, as disclosed in the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 8, 2026, as follows: For Against Abstentions Broker Non-Votes 91,093,535 300,746 184,475 7,200,070”
Ardent Health, Inc. shareholders approved Election of 11 director nominees at the 2026-05-20 meeting.
“The following 11 director nominees were elected to the Company's Board of Directors, as follows: For Withhold Broker Non-Votes Mark Sotir 90,717,572 861,184 7,200,070 Martin J. Bonick 91,240,732 338,024 7,200,070 Peter Bulgarelli 91,267,887 310,869 7,200,070 Peter Bynoe 87,141,918 4,436,838 7,200,070 Suzanne Campion 91,271,694 307,062 7,200,070 Robert A. DeMichiei 91,243,922 334,834 7,200,070 William Goodyear 91,243,902 334,854 7,200,070 Ellen Havdala 86,273,698 5,305,058 7,200,070 Edmondo Robinson 91,328,193 250,563 7,200,070 Rahul Sen 79,335,440 12,243,316 7,200,070 Rob Webb 91,362,871 215,885 7,200,070”
Northwest Bancshares, Inc. shareholders approved Approval of the Northwest Bancshares, Inc. Discounted Stock Purchase Plan at the 2026-05-20 meeting.
“The shareholders approved the proposal regarding the Discounted Stock Purchase Plan as disclosed in the Proxy Statement as follows: For 93,563,437 Against 3,061,203 Abstain 404,445 Broker Non-Votes 19,326,865”
Northwest Bancshares, Inc. shareholders approved Approval of the Northwest Bancshares, Inc. 2026 Equity Incentive Plan at the 2026-05-20 meeting.
“The shareholders approved the proposal regarding the 2026 Equity Incentive Plan as disclosed in the Proxy Statement as follows: For 92,456,593 Against 4,152,782 Abstain 419,710 Broker Non-Votes 19,326,865”
Northwest Bancshares, Inc. shareholders approved Advisory resolution to approve executive compensation at the 2026-05-20 meeting.
“The shareholders approved the proposal regarding the compensation of the named executive officers as disclosed in the Proxy Statement as follows: For 89,274,329 Against 7,171,131 Abstain 583,625 Broker Non-Votes 19,326,865”
Northwest Bancshares, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-20 meeting.
“The shareholders approved the ratification of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. For 114,141,735 Against 1,967,195 Abstain 247,020 Broker Non-Votes —”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.